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2006 Annual Report

Lorraine Iacovitti, PhD, Professor of Neurology at
Jefferson Medical College, a dedicated scientist
who heads the Parkinson’s disease research group
at The Farber Institute for Neurosciences, has
pioneered methods for developing cell replacement
therapies for Parkinson’s using stem cells. Stem cell
research is one of the most promising areas of
science with potential applications including
neurological diseases. Recently, Dr. Iacovitti was
named the inaugural recipient of the Outstanding
Investigator Award from the Tilker Medical Research
Foundation. The foundation is a nonprofit
organization dedicated to accelerating the discovery
of new treatments and cures for a wide range of
neurodegenerative diseases by promoting innovative
stem cell research. This international award will help
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ISSION AND VISION

Mission
Thomas Jefferson University is dedicated to the health sciences.
We are committed to:
• Educating professionals in a variety of disciplines who will form and lead
the integrated healthcare delivery and research teams of tomorrow
• Discovering new knowledge that will define the future of clinical care
through investigation from the laboratory to the bedside, and into
the community
• Setting the standard for quality, compassionate and efficient patient
care for our community and for the nation
We accomplish our mission in partnership with Thomas Jefferson
University Hospital, our education and clinical care affiliate.

fund Dr. Iacovitti’s compelling studies on the
differentiation of dopamine neurons.

Vision
• To be among the premier educators of healthcare practitioners
in the nation
• To define the future of clinical care
• To be a major center for patient-oriented research and clinical trials
• To be a knowledge leader in selected areas of basic research

A message from
Brian G. Harrison and Robert L. Barchi, MD, PhD
These are exciting times for Thomas Jefferson University, full of the bright hope that inspires us all.
We have embarked upon a new era in our history, one that focuses on building on our bold strategic
plan, restructuring programs for the future, and recruiting outstanding new leaders to guide our
continued growth. We are uniquely positioned to accomplish the challenges ahead. Confirming our
market position and fiscal strength, Moody’s Investor Services has assigned an A1 rating to the
university and its bond ratings.
As one of the nation’s premier educators of healthcare practitioners since 1824, Jefferson has a deep
tradition of educational achievement. With the help of an involved community, a committed board, and
our devoted faculty, staff, and alumni, we are continuing to expand our role as a major center for
patient-oriented research, as a focal point for clinical excellence, and as an innovator in clinical care.
One of the most visible – and rising – examples of our success is the new Dorrance H. Hamilton
Medical Education Building, a comprehensive state-of-the-art medical education center and campus
green. The Hamilton Building will enable us to increase the size of our medical college student body to
relieve the predicted national shortage of physicians. Slated for completion in 2007, this magnificent
facility will serve as a tangible reminder that Jefferson’s community of colleges, guided by our strategic
plan, will continue to redefine medical education, research and clinical care by preparing our students
to work as integrated healthcare team members now and throughout the 21st century.
In addition, we have developed plans for a new School of Pharmacy and an Ambulatory Care Center.
To help us succeed, we have recruited internationally recognized experts in vital areas of clinical practice
and basic and translational research. We are studying many drug therapies and identifying biomarkers for
heart failure. This year, the National Institutes of Health (NIH) identified Jefferson Medical College as
Philadelphia’s number one recipient of NIH funding for orthopaedic research. In addition, a recent survey
showed that Jefferson’s outstanding radiologists made more presentations to the international Radiology
Society of North America (RSNA) than any other member’s Department of Radiology.
With our board, our alumni and our friends, we are enhancing our vibrant community of academic
distinction as well as our environment of excellence.
Indeed, over the past year we have made significant progress in our goals for this great institution.
We know through an Employee Satisfaction Survey that our employees have a strong sense of pride in their
association with Jefferson. And with our sustained energy, enthusiasm and vision, Jefferson will continue
to shine – providing bright scholars and clinicians for our community.
Sincerely,

Brian G. Harrison

Robert L. Barchi, MD, PhD

Chair of the Board of Trustees

President, Thomas Jefferson University

E
Integrated teaching and
a simulated team learning
experience are the
hallmarks of Jefferson’s
education plan.

Using our Academic Strategic Plan as a guide, we are developing
new programs to provide the best education for our healthcare
delivery teams. We’re also creating outstanding new programs in
nursing and public health, and pursing strategic alliances with area
universities. In this report, we are proud to share our progress in
meeting our education goals.
DUCATION

JEFFERSON MEDICAL COLLEGE
Jefferson Medical College is proud of the
“Accreditation with Commendation”
designation that our Continuing Medical
Education (CME) Program received from the
Accreditation Council for Continuing Medical
Education (ACCME). This is the second time
that the ACCME, an organization that assures
the quality of educational programs utilized
by physicians to maintain competence and
incorporate new knowledge, has recognized
Jefferson’s CME program with “commendation” –
a designation given to less than 15 percent of all
ACCME-accredited providers. Such acclamations
make Jefferson’s programs attractive for students
and support our physician educators as they
shape the healthcare teams of tomorrow.
The College’s successful transition to a
“Pass/Fail/Honors” system for basic science
grading assisted meeting the team learning goal
outlined in the strategic plan.
For the first time since 1995, when the
university separated from the hospital,
Jefferson Medical College demonstrated a
surplus of revenue over expenses, due in part, to
the half decade of effort by faculty and leadership
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to manage expenses. This accomplishment was
supported by increasing the productivity of
clinical faculty resulting in an upward trend in
the faculty practice plan, Jefferson University
Physicians (JUP), led by John Ogunkeye, MS,
Executive Director and William M. Keane, MD,
Medical Director.
This year, Thomas J. Nasca, MD, MACP,
Jefferson Medical College Dean and Senior Vice
President for Academic Affairs, received three
prestigious honors for his professional and
educational achievements. Dr. Nasca was
awarded the 2006 American College of
Physicians’ Mastership for his stellar career
accomplishments and service to medicine. He
also received the 2006 Dema C. Daley Founders
Award from the Association of Program
Directors in Internal Medicine as a renowned
educator, innovator, and leader. And Saint
Joseph’s University Alumni Association, Medical
Alumni Chapter, presented Dean Nasca with the
Reverend Clarence E. Shaffrey, S.J. Award for
service and outstanding achievement.
JEFFERSON COLLEGE
OF HEALTH PROFESSIONS
Educating our healthcare delivery teams
took a huge leap forward this year with the

Surveying progress at the site of the
Dorrance H. Hamilton Education Building are:
Jefferson Medical College Dean Thomas J. Nasca,
MD, MACP, center; Jefferson College of Health
Professions Dean James B, Erdmann, PhD, left,
and Jefferson College of Graduate Studies
Dean James H. Keen, PhD.

EDUCATION

restructuring of Jefferson College of Health
Professions. The College will now be composed
of three dedicated schools – the School of
Health Professions, the School of Nursing, and
the School of Pharmacy. Janice P. Burke, PhD,
OTR/L, FAOTA, Professor and Chair of
Occupational Therapy, was appointed founding
Dean of the newly formed Jefferson School of
Health Professions. Mary G. Schaal, EdD, RN,
Professor and Chair of Nursing, was named
Dean of the Jefferson School of Nursing.
Rebecca S. Finley, PharmD, MS, was named
the Dean of the Jefferson School of Pharmacy.
Changing Jefferson’s Department of Nursing
to a School of Nursing recognizes the
program’s growth, achievements, and
exceptional nursing education curriculum.
Today, the School of Nursing boasts more
than 600 students, with degrees ranging
from associate to post-master’s certificate.

In conjunction with Jefferson Hospital,
nursing launched a master’s level Certified
Registered Nurse Anesthetist Program and
will graduate its first Associate of Science in
Nursing degree (ASN) class in 2007 with
students from Methodist Hospital and
Geisinger.
Jefferson also recognizes the importance of
educating the next generation of pharmacists.
Rebecca S. Finley, PharmD, MS, with nearly
30 years of experience within the pharmacy
academe and profession, is the founding Dean
for the new Jefferson School of Pharmacy,
with 75 students expected to start in fall 2008.
Building upon Jefferson’s 60 plus years of
experience in pharmacy education, the new
school will fulfill a major goal in our mission,
respond to the shortage of pharmacists, and
insure that Jefferson patients receive safe and
accurate medication.
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THE JEFFERSON COLLEGE
OF GRADUATE STUDIES
The Jefferson College of Graduate Studies
has also advanced its mission this year. The
University Board of Trustees approved the
transfer of all clinical and practice-based
graduate programs to the Jefferson College of
Health Professions so that the College of
Graduate Studies could focus on education in
the biomedical sciences and attract
postdoctoral research fellows to campus.
Joining our leadership team, Dennis Gross,
PhD, is the new Director of the College’s
masters’ programs.
The College’s Office of Postdoctoral Affairs
and the Jefferson Postdoctoral Association
hosted the First Annual Jefferson Postdoctoral
Research Symposium in May, showcasing the
research of 45 Jefferson postdoctoral fellows.
Dr. Christopher Austin, Director of the NIH

Chemical Genomics Center of the National
Human Genome Research Institute delivered
the keynote address.
The College’s Master’s Degree Program in
Public Health, co-directed by David B. Nash,
MD, MBA, the Dr. Raymond C. and Doris N.
Grandon Professor and Chair of Health Policy,
and Richard C. Wender, MD, Alumni
Professor and Chair of Family and Community
Medicine, underscored its educational
excellence by attaining national accreditation
from the Council on Education for Public
Health, the nation’s accrediting body for public
health programs.
Jefferson College of Graduate Studies’ and the
Farber Institute for Neurosciences’ two-year-old
PhD Program in Neuroscience, directed by
Elizabeth J. Van Bockstaele, PhD, attracted
many excellent students. The program provides
a well-rounded course of study and experimental
research in neuroscience.
Also, through new relationships among the
Kimmel Cancer Center at Jefferson and the
departments of Biochemistry and Molecular
Biology, Microbiology and Immunology and
the Jefferson College of Graduate Studies,
there are now four programs leading to a PhD
degree: Biochemistry & Molecular Biology;
Genetics; Immunology and Microbial
Pathogenesis; and Molecular Pharmacology
and Structural Biology. These programs
combine to offer a flexible entry option known

as the Joint PhD Programs, which has now
enrolled 88 PhD students.
Expanding fellowship initiatives
July marked the start of Jefferson’s ACGMEaccredited Fellowship in Sleep Medicine.
Jefferson’s Sleep Disorders Center, a major center
for clinical care, research, and education in sleep
medicine for three decades, hosts the new
program, which is directed by noted sleep
medicine expert, Karl Doghramji, MD.
Under the leadership of David B. Nash, MD,
PhD, Chair of Health Policy, the department
launched a Delaware Valley Schweitzer Fellows
Program. Working as part of the U.S. Schweitzer
Fellows Program, Jefferson graduates in the
health disciplines will participate in a yearlong
community service project and then join others in
a national network of Schweitzer Fellowship
graduates who continue to seek opportunities to
serve in the community.
Another fellowship program, funded by the
American Psychiatric Association (APA), will offer
Jefferson Medical College students more options to
complete their psychiatry rotations. Jefferson was
proud to receive two minority fellowship grants,
under APA’s Minority Fellowship Program, to
increase the knowledge of issues related to ethnic
minority mental health and to improve the quality
of mental health treatment delivered to ethnic
minority populations.

Elizabeth J. Van Bockstaele, PhD, Program Director of the Neuroscience Graduate Program at
Jefferson College of Graduate Studies, works one on one with a student.

R

Jefferson’s Strategic Plan for Research complements its Academic
Plan. It focuses on developing, expanding and strengthening research
in the key areas of neuroscience, cancer biology, cardiovascular
programs, and health outcomes to include robust clinical and
translational research. One goal of this plan is to renew the core grant
for the Kimmel Cancer Center at Jefferson and strengthen our position
in cancer prevention and population science.

ESEARCH

The university’s strategic plan renewed
our commitment to Jefferson’s superb
faculty and identified measures, such
as endowed chairs, expanded
support and renovated research
facilities, to support that commitment.

This year, we have made significant progress
in our research programs, with major
accomplishments in:
CANCER
The Kimmel Cancer Center (KCC) at Jefferson,
a National Cancer Institute (NCI)-designated
cancer center, welcomed many distinguished
members to its team. Internationally renowned
pancreatic cancer surgeon Charles J. Yeo, MD,
the Samuel D. Gross Professor and Chair of
Surgery at Jefferson Medical College, has
expanded the Department of Surgery to include
a Division of Surgical Research, directed by
Thomas Tulenko, PhD. Dr. Yeo recruited
Eugene P. Kennedy, MD, as Assistant Professor
of Surgery from Louisiana State University
Health Sciences Center, New Orleans.
Minimally invasive thoracic and oncologic
surgeon Thomas Andrew d'Amato, MD joined
our surgical team from the University of
California, San Diego. Andrew A. Quong, PhD,
who specializes in nanotechnology and systems
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biology, joined the newly formed Department
of Cancer Biology from Georgetown University.
Michael P. Lisanti, MD, PhD, the 15th mostcited researcher worldwide in biochemistry and
biology, is now a Professor of Cancer Biology at
Kimmel Cancer Center at Jefferson. He joined
the Cancer Center from Albert Einstein College
of Medicine in the Bronx (NY). Richard W.
Haldeman, the Kimmel Cancer Center’s new
Chief Financial Officer, comes to Jefferson
from the Cancer Institute of New Jersey where
he managed its $70 million annual budget. And
longtime Jefferson medical oncologist Edith P.
Mitchell, MD, an advocate of inclusive cancer
prevention, was appointed Director of
Diversity Programs.
In July, Jefferson launched the Department
of Medical Oncology. Neal Flomenberg, MD,
a Jefferson Hospital medical oncologist and
Professor of Medicine at Jefferson Medical
College, was named Interim Chair. The
department focuses on breast and gynecologic
cancer, lung and head and neck cancer,
hematological malignancies and bone
marrow transplant, gastrointestinal cancer,

The Kimmel Cancer Center at Jefferson’s
Andrew A. Quong, PhD, Associate Professor of
Cancer Biology and a nanotechnologist, center,
collaborates with Jeffrey L. Benovic, PhD,
Professor and Chair of Biochemistry and Molecular
Biology, left, and Tim L. Manser, PhD, Professor and
Chair of Microbiology and Immunology, as members
of the cancer center’s integrated science team.

A Jefferson research team found that a known mutation in the
Caveolin-1 gene is present in about 19 percent of all breast
cancers that are fed by estrogen – so called ‘‘estrogen
receptor-positive’’ cells.
RESEARCH
Edith P. Mitchell, MD, Professor of Medical
Oncology, is now Director of Minority Affairs
at the Kimmel Cancer Center at Jefferson.

urinary tract cancers, melanoma and
experimental therapeutics.
In a significant cancer study, led by Renato
Iozzo, MD, Professor of Pathology, Anatomy
and Cell Biology, cell biologists at Jefferson
Medical College and the Kimmel Cancer Center
found that the protein fragment endorepellin
blocks both skin and lung cancer tumors from
progressing in animal models by preventing
their ability to recruit new blood vessels, a
process called angiogenesis. The findings from
this study could lead to a new type of tumor
inhibitor that might be used to prevent cancer
from spreading to other areas in the body,
which would have major implications for cancer
treatments for a range of solid tumors such as
prostate, breast, and lung tumors.
And in the battle against lung cancer,
Jefferson’s Lung Cancer Center offers patients
entry into national trials of new treatment
regimens against lung cancers, recently
conducting a promising trial using both
chemotherapy and radiation. Its multidisciplinary team includes radiation and
medical oncology specialists with extensive
expertise in treating lung cancer, as well as
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thoracic surgeons, pulmonary disease
specialists, radiologists, nurses and
social workers.
Neurological surgeon David W. Andrews,
MD, and radiation oncologist Maria WernerWasik, MD, discovered that a slow-growing,
benign but potentially devastating brain tumor
called an acoustic schwannoma, usually
removed by surgery that can potentially damage
surrounding cranial nerves, can be treated with
lower doses of radiation therapy. Using small,
fractionated lower doses of radiation resulted in
excellent tumor control and slightly better
hearing preservation than higher doses. Lower
radiation doses mean shorter treatment times
and fewer visits. Patients in their study received
the lower dose over 26 treatments, while those
who received the higher dose required 30
treatments. They reported their results in
November 2006 at the annual meeting of the
American Society for Therapeutic Radiology
and Oncology.
Advances in breast cancer research
Jefferson’s breast cancer research has also made
significant advances. A team of researchers,

Rosario Scalia, MD, PhD, Associate Professor
of Physiology, brings us closer to understanding
cardiovascular disease in diabetes and insulin
resistance by studying why pharmacological
inhibition of certain proteases found in endothelial
cells and in circulating leukocytes prevents
vascular inflammation.

led by Richard G. Pestell, MB, BS, MD, PhD,
FRACP, Director of Kimmel Cancer Center at
Jefferson and cell biologist Michael P. Lisanti,
MD, PhD, Professor of Cancer Biology at
Jefferson Medical College, discovered evidence
suggesting that a mutation in a gene that
normally helps block the formation of breast
tumors could play a role in the initiation of a
major form of breast cancer. Working with
researchers at the Albert Einstein College of
Medicine in New York, the Jefferson research
team found that a known mutation in the
Caveolin-1 gene is present in about 19 percent
of all breast cancers that are fed by estrogen – so
called “estrogen receptor-positive” cells.
Caveolin-1 mutations may be involved in the
development of estrogen-positive human breast
cancer, which accounts for about 70 percent of
all breast cancers.

In another gene study led by Dr. Pestell,
Kimmel Cancer Center researchers found that the
activity of a gene that commandeers other cancercausing genes, returning them to normal, can
predict the prognosis of an individual with breast
cancer. Called Dachshund, the gene plays a role
in determining the fate of some types of cells.
Jefferson researchers showed that Dachshund could
block breast cancer growth in mice and also could
halt breast cancer from invading other tissues.
Other researchers led by Adam P. Dicker, MD,
PhD, Professor of Radiation Oncology, found
that inhibiting a particular cancer causing gene
can enhance the cell-killing effects of radiation.
The team used zebrafish and antisense
technology to show that the drug flavopiridol
works by blocking the activity of the gene cyclin
D1, which is made in excessive amounts in about
half of all breast cancers.
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50 years continuous NIH research funding
Continuing to amaze the scientific world, this
year, eminent Jefferson virologist Hilary
Koprowski, MD, Professor of Cancer Biology
the first scientist to develop the oral polio
vaccine – was honored by National Institute of
Allergy and Infectious Diseases Director
Anthony Fauci, MD, for 50 years of continuous
funding from the National Institutes of Health.
Dr. Koprowski pioneered the development of
monoclonal antibodies against cancer.
CARDIOLOGY
Jefferson’s strategic plan outlined the need to
strengthen heart failure and vascular research
by recruiting new researchers and by expanding
basic and translational cardiology research.
Cardiovascular research and treatment at
Jefferson is especially strong in treating heart

failure, hypertension, thrombosis and vascular
biology, and metabolic vascular disease. We’re
expanding our Center for Vascular Pathobiology and adding more clinical researchers
for our Metabolic Center. Our research is
well funded and our scientists have published
in 300 peer-reviewed publications over the
last five years.
Jefferson cardiology researchers found an
elevated level of GRK2, a protein that plays an
important regulatory role in heart failure, in
patients with failing hearts. Walter J. Koch,
PhD, Director of the Center for Translational
Medicine in the Department of Medicine,
believes that these findings add to the growing
evidence that GRK2 is a biomarker for heart
failure. In a study presented at the September
2006 10th Annual Scientific Meeting of the
Heart Failure Society of America, Amit Mittal,
MD, heart failure research fellow in the
Department of Medicine, reported that GRK2
levels in patients with heart failure were three
to four times higher when compared to
patients with normal heart function.
And internationally recognized cardiologist
and researcher, Thomas L. Force, MD, joined

Researchers at Jefferson Medical College are enjoying
the highest level of National Institutes of Health (NIH)
funding for orthopaedic research in Philadelphia.

Paul J. DiMuzio, MD, Associate Professor of
Surgery, Jefferson Medical College, and
Negar Golesorkhi, MD, Resident, Department of
Surgery, review results of research to create a
novel graft that would bypass blood vessels in
the heart and legs clogged by atherosclerosis.
This vascular bypass graft has the potential of
helping thousands of patients, including those
suffering with atherosclerosis, a common
condition known as “hardening of the arteries.”
The research is funded through grants from the
National Institutes of Health and the American
Heart Association.

Jefferson as Clinical Director of the Center for
Translational Medicine in the Department of
Medicine. The Center focuses on leading-edge
basic molecular biomedical research and its
translation into the most efficient and tailored
forms of diagnosis, treatment, and prevention.
Dr. Force is currently principal investigator for
several National Institutes of Health grants that
support this research.
Researchers in Jefferson’s Cardiac
Catheterization Laboratory have found that
nicardipine, a commonly available calcium
channel blocker, is effective in reversing the
‘no-reflow’ phenomenon that affects as many
as 50,000 patients annually who undergo
angioplasty – a procedure to clear arteries that
have been clogged up or narrowed by plaque.
Michael P. Savage, MD, Cardiac
Catheterization Laboratory Director and
Associate Professor of Medicine, observes
that ‘no-reflow’ can be a potentially serious
complication that places patients at high risk
of heart attack or even death. Jefferson heart
researchers report that intracoronary
nicardipine was demonstrated to be a safe

and highly effective pharmacological agent
to reverse ‘no-reflow’ during angioplasty.
Strengthening our basic science team,
Marion J. Siegman, PhD, Chair, Department
of Molecular Physiology and Biophysics,
recruited Associate Professors of Physiology
Ji-Fang Zhang, PhD, and Masumi Eto, PhD,
to Jefferson’s basic research team. Dr. Zhang’s
research focuses on voltage-gated Ca2+
channels, which are vital for muscle
contraction, neurotransmitter release,
neurodevelopment, and gene expression.
Dr. Eto’s research explores the regulation of
smooth muscle contraction. Both researchers
are supported by grants from NIMH and
NINDS of the National Institutes of Health.
Jefferson ranks second nationally in the rate
of growth in NIH funding for research over
the past 10 years.
Orthopaedic research recognition
Researchers at Jefferson Medical College are
enjoying the highest level of National Institutes
of Health (NIH) funding for orthopaedic
research in Philadelphia – an outstanding
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achievement. Their sophisticated work, directed
by Irving M. Shapiro, PhD, Professor of
Orthopaedic Surgery and Director of the
Division of Orthopaedic Research, offers
promise to those who experience pain and
disability from degenerative spinal disease.
It contributes, also, to Jefferson’s reputation as
a center of orthopaedic excellence.
Neuroscience
Jefferson’s neuroscience program is unequaled
in the region. This year, distinguished
neurologists joined the Jefferson community
of researchers. JUP physicians Daniel Erik
Kremens, MD, JD, Clinical Assistant Professor
of Neurology, and Tsao-Wei Liang, MD,
Assistant Professor of Neurology at Jefferson
Medical College – both noted neurologists
who have dedicated their careers to treating
patients with movement disorders – were
recruited to create a Movement Disorders
Program. Led by A. M. Rostami, MD, PhD,
Professor and Chair of Neurology, the scientists
will direct a host of improved treatments to
combat movement disorders due to Parkinson’s

Neurological surgeon David W. Andrew’s expertise in brain
surgery is legendary. His recent research, in collaboration
with radiation oncologist Maria Werner-Wasik, MD,
Associate Professor of Radiation Oncology, discovered that
lower doses of radiation therapy provided excellent tumor
control and slightly more hearing preservation in treating a
benign but potentially devastating brain tumor called
acoustic schwannoma usually associated with hearing loss.

RESEARCH
disease, stroke, multiple sclerosis (MS), or other
chronic neurological conditions.
Recently, Dr. Rostami led a study, reported in
the journal Multiple Sclerosis, showing that a
soy-based natural substance, called BowmanBirk Inhibitor Concentrate, appears to have
amazing restorative powers when given to
animals with MS.
Patients can also participate in clinical
studies of new therapeutic agents with
established researchers such as Jay Schneider,
PhD, Director of the Parkinson’s Disease
Research Unit, and Professor of Pathology,
Anatomy and Cell Biology.
For patients with later stage Parkinson’s,
Jefferson scientists, led by Ashwini D. Sharan,
MD, Assistant Professor of Neurological
Surgery at Jefferson Medical College, can
provide a new surgical procedure called Deep
Brain Stimulation (DBS) at Jefferson Hospital.
DBS enables neurological surgeons to supply
controlled electrical signals through electrodes
implanted in the brain, to attempt to reestablish
the brain’s disordered circuitry.a

L
Judith L. Bachman, the University’s Senior
Vice President for Strategic Initiatives, right, and
Janet E. Burnham, Jefferson Hospital’s Senior
Vice President for Planning, coordinated the
committees whose participation helped shape
the strategic plan for Jefferson. They are standing
on the new bridge entrance to the hospital which
improves access to both the hospital and physician
offices. The bridge connects the InterPark garage
on 10th Street to the hospital’s second-floor atrium.

EADERSHIP
The university’s President and Board of
Trustees have achieved new heights in an
already stellar history of leadership as they
guide Jefferson in developing and adopting a
bold strategic agenda to design the future of
clinical care and develop tomorrow’s team of
integrated healthcare professionals.
Bringing development initiatives for the
university and hospital under The Jefferson
Foundation efficiently strengthens our
commitment to education, research and patient
care. Jefferson’s bold move to develop a stateof-the-art education facility for our students –
one that uses simulated clinical situations and
manikins – brings with it a plan to create an
identity that transforms our campus into an
oasis of green for our students, faculty,
employees and community members. Our
institutional and civic commitment to improve
our surroundings includes a promise for
revitalized restaurant and retail space along
Walnut Street.
Under our new facilities master plan,
developed in conjunction with Jefferson Hospital,
our faculty, corporate and administrative leaders
are engaged in redesigning educational programs,
restructuring our faculty practice plan and
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improving information technology infrastructure
for greater efficiency and cost-effectiveness. At
the same time, we have moved forward in our
commitment to making Jefferson an employer of
choice for staff and faculty. We are engaged in
leading Jefferson’s transformation on all levels.

Nursing Student Hope Lee, RN, right in photo above,
is pursuing her BSN at Jefferson College of Health
Professions, and preparing to deliver her
second child soon. Her mentor Mary Bouchard, RN,
left, says that her work at Casa Fernace, a South
Philadelphia residence for Seniors affiliated with
the Philadelphia Senior Center, has been an
extraordinarily successful venture into the
community for a nursing student. Hope’s
relationships in reaching out to the residents are
warm, humorous and caring. Residents such as
June Lees look forward to her visits for health
education and camaraderie. Hope’s interactions
with residents are filled with hugs, tender moments
and a genuine expression of her concern for their
welfare. Hearing of her presence at the residence,
several residents (including a 94-year-old woman,
Mrs. Barabas) made a special effort to come down
to see Hope and check upon the impending birth
of her daughter whose name will be Sky. Hope is
The University’s team of senior administrators is composed of, from left, Richard J. Schmid, Vice President for Finance and Chief Financial Officer; Cristina Cavalieri,

considering a birthday party for Sky’s delivery

BSN, Esq., Vice President and University Counsel; James B. Erdmann, PhD, Dean, Jefferson College of Health Professions; Richard G. Pestell, MD, PhD, FRACP,

complete with balloons and cake – just as she

Director, Kimmel Cancer Center at Jefferson; David R. Lepper, Senior Vice President for Development; Thomas J. Nasca, MD, MACP, Dean, Jefferson Medical College

arranged for her son, Artemis. Hope Lee, RN,

and Senior Vice President for Academic Affairs; Judith L. Bachman, Senior Vice President for Strategic Initiatives; Bruce Metz, PhD, Chief Information Officer;

exemplifies everything Jefferson could hope for

James H. Keen, PhD, Dean, Jefferson College of Graduate Studies and Vice President for International Affairs; Steven E. McKenzie, MD, PhD,

in a nurse.

Vice President for Research.
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INANCIALS

Commencement 2006,
At the heart of Jefferson’s
mission, the next generation
of healthcare professionals
receives their degrees.

O p e r a t i n g R e ve n u e s

• Physician’s professional services
• Grants and contracts
• Tuition and Fees
• Sales from auxiliary activities
• Endowment payout
• State appropriations
• Contributions
• Other sources
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Operating Expenses
37.7%
23.4%
10.8%
19.1%
1.2%
1.9%
0.4%
5.5%

• Salaries and wages
• Employee and faculty benefits
• Depreciation
• Heat, light and power
• Debt service
• Other

53.4%
11.9%
3.2%
3.2%
1.2%
27.1%

Thomas Jefferson University
June 30, 2006 and 2005 ($ in Millions)

How We Received Our Revenues

2006

2005

Physician’s professional services
Grants and contracts
Tuition and Fees
Sales from auxiliary activities
Endowment payout
State appropriations
Contributions
Other sources

203.2
126.0
58.0
103.2
6.6
10.5
2.2
29.5

190.4
125.9
52.5
94.9
9.8
10.4
6.4
28.5

$539.2

$518.8

284.9
63.6
17.3
17.1
6.2
144.5

267.3
64.5
17.8
15.0
5.9
145.0

$533.6

$515.5

$5.6

$3.3

Non-operating Gains/(Losses), Net

$13.0

$13.3

Net Income/(Loss)

$18.6

$16.6

Operating Revenues
How We Spent Our Revenues
Salaries and wages
Employee and faculty benefits
Depreciation
Heat, light and power
Debt service
Other

Operating Expenses
Subtotal
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Thomas Jefferson University Administration

Chair

Alumni Trustees

Robert L. Barchi, MD, PhD

Microbiology and Immunology

Brian G. Harrison

Lisa Ann Plowfield, PhD, RN
Peter V. Scoles, M.D.
Charles J. Stahl, MD

President, Thomas Jefferson University

Timothy Manser, PhD

Jefferson College of Graduate
Studies Programs

Judith L. Bachman

Neurology

Biochemistry & Molecular Biology

Senior Vice President for Strategic Initiatives

Abdolmohamad Rostami, MD, PhD

Diane E. Merry, PhD

Cristina Cavalieri, BSN, Esq.

Neurological Surgery

Cell and Developmental Biology

Vice President and University Counsel

Robert H. Rosenwasser, MD

Theodore F. Taraschi, PhD

James B. Erdmann, PhD

Obstetrics and Gynecology

Genetics

Dean, Jefferson College of Health Professions

Louis Weinstein, MD

Linda D. Siracusa, PhD

James H. Keen, PhD

The Paul A. and Eloise B. Bowers Professor of
Obstetrics and Gynecology

Immunology & Microbial Pathogenesis

Ophthalmology

Molecular Pharmacology & Structural Biology

David R. Lepper

William S. Tasman, MD

Jeffrey L. Benovic, PhD

Senior Vice President for Development

Oral and Maxillofacial Surgery

Molecular Physiology and Biophysics

Steven E. McKenzie, MD, PhD

Robert J. Diecidue, MD, DMD, MBA

Rosario G. Scalia, MD, PhD

Michael R. Stiles, Esq.

Vice President for Research

Orthopaedic Surgery

Neurosciences

Audit and Compliance

Bruce Metz, PhD

Richard H. Rothman, MD, PhD

Elisabeth J. Van Bockstaele, PhD

Chief Information Officer

The James Edwards Professor of
Orthopaedic Surgery

Tissue Engineering & Regenerative Medicine

Emeritus Trustees

Lennox K. Black
Edward C. Driscoll
Mrs. Samuel M.V. Hamilton
James W. Stratton

Term Trustees

Robert S. Adelson
Robert L. Barchi, MD, PhD
David R. Binswanger
Kenneth H. Boone
Ira Brind, Esq.
Carter R. Buller, Esq.
Patricia A. Coulter
Jack Farber
Richard C. Gozon
Kenneth A. Graham
Brian G. Harrison
Ernest E. Jones, Esq.
Christopher J. Kneizys
Charles G. Kopp, Esq.
Leonard I. Korman
James E. Ksansnak
Thomas J. Lewis
Ira M. Lubert
Douglas J. MacMaster Jr., Esq.
Josephine C. Mandeville
Peter M. Mattoon, Esq.
Joseph J. McLaughlin
Thomas B. Morris Jr., Esq.
Britton H. Murdoch
Jeffrey P. Orleans
Lawrence Smith
Gerard H. Sweeney
Brian P. Tierney, Esq.

Commonwealth Trustees

John J. Leonard, Esq.
John A. Salvatore
Robert Scandone, Esq.
Michael R. Stiles, Esq.
Cuyler H. Walker, Esq.
Committee Chairs

Cuyler H. Walker

Dean, Jefferson College of Graduate Studies
Vice President for International Affairs

Biotechnology

Thomas J. Nasca, MD, MACP

Brian G. Harrison

Dean, Jefferson Medical College
Senior Vice President for Academic Affairs

Executive

Gerard H. Sweeney
Facilities Advisory

Richard C. Gozon
Finance

Richard G. Pestell, MD, PhD, FRACP

Thomas B. Morris Jr., Esq.
Human Resource

David R. Binswanger
Joint Development

Peter V. Scoles, MD
Scientific and Academic Affairs

Brian G. Harrison, Co-Chair
TJU-TJUH Joint Management

William M. Keane, MD
The Herbert Keen, MD, Professor of
Otolaryngology – Head and Neck Surgery

Director, Kimmel Cancer Center at Jefferson

Richard J. Schmid
Vice President for Finance
Chief Financial Officer

Pathology, Anatomy and Cell Biology

Fred Gorstein, MD
Pediatrics

Roy Proujansky, MD

Peter M. Mattoon, Esq.
Governance

Otolaryngology – Head and Neck Surgery

Noreen J. Hickok, PhD
MD/PhD Program

Scott A. Waldman, MD, PhD
MS Basic Sciences

Dennis M. Gross, PhD
MS Public Health

David B. Nash, MD, MBA
MS Public Health

Jefferson Medical College
Department Chairs 2006

The Robert Brent Professor of Pediatrics

Richard C. Wender, MD

Anesthesiology

Pharmacology and Experimental Therapeutics

Scott A. Waldman, MD, PhD

Jefferson College of Health
Professions

Physiology

Bioscience Technologies

Zvi Grunwald, MD
Biochemistry and Molecular Biology

Jeffrey L. Benovic, PhD
Cancer Biology

Richard G. Pestell, MD, PhD
Dermatology and Cutaneous Biology

Jouni J. Uitto, MD, PhD
Emergency Medicine

Theodore A. Christopher, MD, FACEP
Family and Community Medicine

Richard C. Wender, MD

Marion J. Siegman, PhD
Psychiatry and Human Behavior

Michael J. Vergare, MD
The Daniel Lieberman Professor of
Psychiatry and Human Behavior
Radiation Oncology

Walter J. Curran Jr., MD
Radiology

Vijay Rao, MD

The Alumni Professor of Family Medicine

Rehabilitation Medicine

Health Policy

David B. Nash, MD, MBA

The Michie Professor of
Rehabilitation Medicine

Dr. Raymond C. and Doris N. Grandon Professor
of Health Policy

Surgery

Medicine

The Samuel D. Gross Professor of Surgery

Arthur Michael Feldman, MD, PhD
The Magee Professor of Medicine

John L. Melvin, MD, MMSc

Shirley E. Greening, JD, CT (ASCP),
CFIAC
General Studies

Caroline Golab, PhD
Nursing

Mary G. Schaal, EdD, RN
Occupational Therapy

Janice Burke, PhD, OTR/L, FAOTA
Physical Therapy

Penny G. Kroll, PhD, PT
Radiologic Sciences

Frances Gilman, MS, RT (R)
(CT)(MR)(CV)

Charles J. Yeo, MD
Urology

Leonard G. Gomella, MD
The Bernard W. Godwin Professor of
Prostate Cancer
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Thomas Jefferson University is committed to
providing equal educational and employment
opportunities for all persons, without regard to race,
color, national, and ethnic origin, religion, sexual
orientation, sex, age, handicap, or veteran’s status.
Thomas Jefferson University complies with all
relevant local ordinances and state and federal
statutes in the administration of its educational
and employment policies and is an Affirmative
Action Employer.
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